Invictus MD Strategies Corp.

OTCPK:IVIT.F Stock Report

Market Cap: US$1.2k

Invictus MD Strategies Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Invictus MD Strategies's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals Industry Growth6.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Oct 2019

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Invictus MD Strategies makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:IVIT.F Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Oct 197-3470
31 Jul 197-37150
30 Apr 195-37200
31 Jan 195-36180
31 Oct 182-17240
31 Jul 181-19160
30 Apr 183-16130
31 Jan 182-20150
31 Oct 172-28150
31 Jul 172-16130
30 Apr 172-14120
31 Jan 173-660
31 Oct 164-130
31 Jul 165-130
30 Apr 165020
31 Jan 164020
31 Oct 152-210
31 Jul 150-110
30 Apr 150-100
31 Jan 150-100

Quality Earnings: Insufficient data to determine if IVIT.F has high quality earnings.

Growing Profit Margin: Insufficient data to determine if IVIT.F's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if IVIT.F's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare IVIT.F's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if IVIT.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.


Return on Equity

High ROE: IVIT.F has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies